Kypros Nicolaides

Last updated

Kypros Nicolaides
Kypros Nicolaides crop.JPG
Nicolaides in 2011
Born (1953-04-09) 9 April 1953 (age 70)
Paphos, Cyprus
NationalityCypriot
CitizenshipBritish
Alma mater King's College London

Kyprianos "Kypros" Nicolaides FRCOG (born 9 April 1953) is a Greek Cypriot physician of British citizenship, Professor of Fetal Medicine at King's College Hospital, London. He is one of the pioneers of fetal medicine and his discoveries have revolutionised the field. [1] He was elected to the US National Academy of Medicine in 2020 for 'improving the care of pregnant women worldwide with pioneering rigorous and creative approaches, and making seminal contributions to prenatal diagnosis and every major obstetrical disorder'. [2] This is considered to be one of the highest honours in the fields of health and medicine and recognises individuals who have demonstrated outstanding professional achievement and commitment to service. [3]

Contents

Early life and education

Nicolaides was born in 1953 in Paphos, Cyprus, and attended The English School in Nicosia. He studied Biochemistry and Physiology at King's College London and Medicine at King's College School of Medicine and Dentistry in London, graduating in 1978. Soon after graduation, in 1980, he joined the Department of Obstetrics and Gynaecology, doing research with Professor Stuart Campbell and Professor Charles Rodeck as his first assistant, working mainly on fetoscopic techniques and procedures. [4] His manual dexterity at procedures and the Rodeck-Nicolaides team soon produced important papers on the use of fetoscopy in the management of a wide range of conditions such as Rhesus iso-immunization, fetal hydrops and intrauterine growth restriction, and procedures such as blood and tissue sampling in the diagnosis of single gene defects. [4]

Professional career

In 1986 Nicolaides became Director of the Harris Birthright Research Centre for Fetal Medicine, the first Fetal Medicine Unit in the United Kingdom, opened in 1984 by Diana, Princess of Wales. His programme of research and teaching made King's College Hospital the largest and most renowned centre for fetal medicine in the world. [4]

He has held the position of Professor of Fetal Medicine at King's College London since 1992. [5] He has been a member of several study groups of the Royal College of Obstetricians and Gynaecologists, the Chairman of the Educational Committee of the World Association of Perinatal Medicine and the Chairman of the Scientific Committee of the International Society of Ultrasound in Obstetrics and Gynecology.

He is also the Founder and Chairman of the UK Charity, the Fetal Medicine Foundation, which he set up in 1995. [6] The main source of income of the Charity is a private clinic, and the Fetal Medicine Foundation has donated more than £45 million to finance the training of doctors from around the world and to carry out major multi-centre research studies in fetal medicine. [6] The Fetal Medicine Foundation also organises the yearly World Congress in Fetal Medicine, which is attended by more than 2,000 participants and has implemented a series of internet-based educational courses for doctors and patients which are available free of charge. [7]

Nicolaides has authored over 1,500 peer-reviewed journal articles and more than 30 books and monographs. He has an H-index of 185, which is the highest of any Obstetrician & Gynaecologist in the world, and has had his research cited over 130,000 times. [8] He has supervised 55 doctors in obtaining PhD and MD qualifications and has provided training in Fetal Medicine to over 700 doctors from 50 countries.

Nicolaides has developed methods of (i) screening for premature birth (which is the main cause of perinatal morbidity and mortality) by measurement of cervical length and prevention through the use of vaginal progesterone, [9] (ii) screening for pre-eclampsia (which is one of the main causes of maternal mortality) by measurement of blood flow to the uterus by Doppler and measurement of blood pressure and the hormone placental growth factor and prevention through the use of aspirin, [10] (iii) methods of early screening for chromosomal abnormalities through the measurement of nuchal translucency, [11] [12] and spina bifida through the ‘lemon and banana’ signs, [13] and (iv) methods of fetal therapy including fetal blood transfusions for red cell isoimmunized pregnancies, [14] [15] thoraco-amniotic shunting for fetal pleural effusions, [16] endoscopic laser surgery for identical twin pregnancies with severe twin-to-twin transfusion syndrome in collaboration with Professor Yves Ville [17] and endoscopic placement of a balloon in the fetal trachea for the treatment of severe diaphragmatic hernia in collaboration with Professors Jan Deprest and Eduard Gratacos. [18] He has recently proposed a new model of pregnancy care - "Turning the Pyramid of Prenatal Care". [19] This aims to assess the risk for most of the relevant pregnancy complications affecting mother and unborn child during a hospital visit at 11–13 weeks of gestation and, on the basis of such risks, provide personalised care to reduce an adverse outcome. [20]

Awards and recognitions

Television

The BBC television programme Life Before Birth is mainly about his work. [29]

Nicolaides also stars in the first episode of Netflix's docuseries The Surgeon's Cut, which was released in December 2020. [30] This episode follows Nicolaides at King's College Hospital in London where his ground-breaking work in endoscopic laser surgery is used to treat twin-to-twin transfusion syndrome, a life-threatening prenatal condition. [30]

Related Research Articles

<span class="mw-page-title-main">Amniocentesis</span> Sampling of amniotic fluid done mainly to detect fetal chromosomal abnormalities

Amniocentesis is a medical procedure used primarily in the prenatal diagnosis of genetic conditions. It has other uses such as in the assessment of infection and fetal lung maturity. Prenatal diagnostic testing, which includes amniocentesis, is necessary to conclusively diagnose the majority of genetic disorders, with amniocentesis being the gold-standard procedure after 15 weeks' gestation.

<span class="mw-page-title-main">Selective reduction</span> Abortion of one or more (but not all) fetuses in a multiple pregnancy

Selective reduction is the practice of reducing the number of fetuses in a multiple pregnancy, such as quadruplets, to a twin or singleton pregnancy. The procedure is also called multifetal pregnancy reduction. The procedure is most commonly done to reduce the number of fetuses in a multiple pregnancy to a safe number, when the multiple pregnancy is the result of use of assisted reproductive technology; outcomes for both the mother and the babies are generally worse the higher the number of fetuses. The procedure is also used in multiple pregnancies when one of the fetuses has a serious and incurable disease, or in the case where one of the fetuses is outside the uterus, in which case it is called selective termination.

<span class="mw-page-title-main">Obstetric ultrasonography</span> Use of medical ultrasonography in pregnancy

Obstetric ultrasonography, or prenatal ultrasound, is the use of medical ultrasonography in pregnancy, in which sound waves are used to create real-time visual images of the developing embryo or fetus in the uterus (womb). The procedure is a standard part of prenatal care in many countries, as it can provide a variety of information about the health of the mother, the timing and progress of the pregnancy, and the health and development of the embryo or fetus.

<span class="mw-page-title-main">Prenatal testing</span> Testing for diseases or conditions in a fetus

Prenatal testing consists of prenatal screening and prenatal diagnosis, which are aspects of prenatal care that focus on detecting problems with the pregnancy as early as possible. These may be anatomic and physiologic problems with the health of the zygote, embryo, or fetus, either before gestation even starts or as early in gestation as practicable. Screening can detect problems such as neural tube defects, chromosome abnormalities, and gene mutations that would lead to genetic disorders and birth defects, such as spina bifida, cleft palate, Down syndrome, Tay–Sachs disease, sickle cell anemia, thalassemia, cystic fibrosis, muscular dystrophy, and fragile X syndrome. Some tests are designed to discover problems which primarily affect the health of the mother, such as PAPP-A to detect pre-eclampsia or glucose tolerance tests to diagnose gestational diabetes. Screening can also detect anatomical defects such as hydrocephalus, anencephaly, heart defects, and amniotic band syndrome.

<span class="mw-page-title-main">Twin-to-twin transfusion syndrome</span> Medical condition

Twin-to-twin transfusion syndrome (TTTS), also known as feto-fetal transfusion syndrome (FFTS), twin oligohydramnios-polyhydramnios sequence (TOPS) and stuck twin syndrome, is a complication of monochorionic multiple pregnancies in which there is disproportionate blood supply between the fetuses. This leads to unequal levels of amniotic fluid between each fetus and usually leads to death of the undersupplied twin and, without treatment, usually death or a range of birth defects or disabilities for a surviving twin, such as underdeveloped, damaged or missing limbs, digits or organs, especially cerebral palsy.

In obstetrics, gestational age is a measure of the age of a pregnancy taken from the beginning of the woman's last menstrual period (LMP), or the corresponding age of the gestation as estimated by a more accurate method if available. Such methods include adding 14 days to a known duration since fertilization, or by obstetric ultrasonography. The popularity of using this measure of pregnancy is due to the fact that menstrual periods are usually noticed, while there is generally no convenient way to discern when fertilization or implantation occurred. Gestational age is contrasted with fertilization age which takes the date of fertilization as the start date of gestation, and pregnancy which begins with implantation.

<span class="mw-page-title-main">Abdominal pregnancy</span> Medical condition

An abdominal pregnancy is a rare type of ectopic pregnancy where the embryo or fetus is growing and developing outside the womb in the abdomen, but not in the Fallopian tube, ovary or broad ligament.

<span class="mw-page-title-main">Cervical cerclage</span> Obstetrics medical procedure

Cervical cerclage, also known as a cervical stitch, is a treatment for cervical weakness, when the cervix starts to shorten and open too early during a pregnancy causing either a late miscarriage or preterm birth. In women with a prior spontaneous preterm birth and who are pregnant with one baby, and have shortening of the cervical length less than 25 mm, a cerclage prevents a preterm birth and reduces death and illness in the baby.

<span class="mw-page-title-main">Placenta accreta spectrum</span> Medical condition

Placenta accreta occurs when all or part of the placenta attaches abnormally to the myometrium. Three grades of abnormal placental attachment are defined according to the depth of attachment and invasion into the muscular layers of the uterus:

  1. Accreta – chorionic villi attached to the myometrium, rather than being restricted within the decidua basalis.
  2. Increta – chorionic villi invaded into the myometrium.
  3. Percreta – chorionic villi invaded through the perimetrium.

Hemolytic disease of the newborn (anti-Kell1) is the second most common cause of severe hemolytic disease of the newborn (HDN) after Rh disease. Anti-Kell1 is becoming relatively more important as prevention of Rh disease is also becoming more effective.

Placental insufficiency or utero-placental insufficiency is the failure of the placenta to deliver sufficient nutrients to the fetus during pregnancy, and is often a result of insufficient blood flow to the placenta. The term is also sometimes used to designate late decelerations of fetal heart rate as measured by cardiotocography or an NST, even if there is no other evidence of reduced blood flow to the placenta, normal uterine blood flow rate being 600mL/min.

Stuart Campbell DSc FRCPEd FRCOG FACOG, was born in Glasgow, Scotland, and graduated from the medical school of Glasgow University. During his training he worked with Ian Donald, who had published some of the first papers on the use of ultrasound in obstetrics.

<span class="mw-page-title-main">Maternal–fetal medicine</span> Branch of medicine

Maternal–fetal medicine (MFM), also known as perinatology, is a branch of medicine that focuses on managing health concerns of the mother and fetus prior to, during, and shortly after pregnancy.

Hemolytic disease of the newborn (anti-RhE) is caused by the anti-RhE antibody of the Rh blood group system. The anti-RhE antibody can be naturally occurring, or arise following immune sensitization after a blood transfusion or pregnancy.

<span class="mw-page-title-main">Velamentous cord insertion</span> Velamentous placenta

Velamentous cord insertion is a complication of pregnancy where the umbilical cord is inserted in the fetal membranes. It is a major cause of antepartum hemorrhage that leads to loss of fetal blood and associated with high perinatal mortality. In normal pregnancies, the umbilical cord inserts into the middle of the placental mass and is completely encased by the amniotic sac. The vessels are hence normally protected by Wharton's jelly, which prevents rupture during pregnancy and labor. In velamentous cord insertion, the vessels of the umbilical cord are improperly inserted in the chorioamniotic membrane, and hence the vessels traverse between the amnion and the chorion towards the placenta. Without Wharton's jelly protecting the vessels, the exposed vessels are susceptible to compression and rupture.

<span class="mw-page-title-main">Monoamniotic twins</span> Identical twins sharing the same amniotic sac in the womb

Monoamniotic twins are identical or semi-identical twins that share the same amniotic sac within their mother's uterus. Monoamniotic twins are always monochorionic and are usually termed Monoamniotic-Monochorionic twins. They share the placenta, but have two separate umbilical cords. Monoamniotic twins develop when an embryo does not split until after formation of the amniotic sac, at about 9–13 days after fertilization. Monoamniotic triplets or other monoamniotic multiples are possible, but extremely rare. Other obscure possibilities include multiples sets where monoamniotic twins are part of a larger gestation such as triplets, quadruplets, or more.

<span class="mw-page-title-main">Monochorionic twins</span> Identical twins that share the same placenta

Monochorionic twins are monozygotic (identical) twins that share the same placenta. If the placenta is shared by more than two twins, these are monochorionic multiples. Monochorionic twins occur in 0.3% of all pregnancies. Seventy-five percent of monozygotic twin pregnancies are monochorionic; the remaining 25% are dichorionic diamniotic. If the placenta divides, this takes place before the third day after fertilization.

<span class="mw-page-title-main">Charles Richard Whitfield</span> Northern Irish obstetrician and gynaecologist

Charles Richard Whitfield FRCOG, FRCP(G) was a Northern Irish obstetrician and gynaecologist who was a pioneer of maternal-fetal (perinatal) medicine. His primary interest was in fetal medicine, a branch of obstetrics and gynaecology that focuses on the assessment of the development, growth and health of the baby in the womb. He was also an early proponent of subspecialisation within the fields of obstetrics and gynaecology, a practice that is common today.

<span class="mw-page-title-main">Sally Collins</span>

Sally L. Collins BSc BMBCh DPhil FRCOG is a Professor of Obstetrics in the Nuffield Department of Women’s and Reproductive Health, University of Oxford and a Consultant Obstetrician subspecializing in Feto-Maternal Medicine at the John Radcliffe Hospital, Oxford. She is also a lecturer in Medical Sciences at St. Anne’s College, University of Oxford.

Beryl Rice Benacerraf was an American radiologist and professor of obstetrics, gynecology and reproductive biology and radiology at Harvard Medical School. She was a pioneer in the use of prenatal ultrasound to diagnose fetal abnormalities, including Down syndrome. In 2021, she was recognized as a "Giant in Obstetrics and Gynecology" by the American Journal of Obstetrics & Gynecology.

References

  1. "The Fetal Medicine Foundation Belgium - Biography: Professor Kypros Nicolaides". www.fmfb.be. Retrieved 10 September 2017.
  2. "King's College Hospital - News". www.kch.nhs.uk. Archived from the original on 25 December 2021. Retrieved 20 November 2020.
  3. 1 2 "National Academy of Medicine Elects 100 New Members". 19 October 2020.
  4. 1 2 3 4 Kratochwil, A. (12 January 2000). "Presentations of the 1999 Ian Donald Gold Medals". Ultrasound in Obstetrics & Gynecology. 16 (1): 106–107. doi: 10.1046/j.1469-0705.2000.00176.x . PMID   11084981.
  5. "Kypros Nicolaides - Research Portal, King's College, London". kclpure.kcl.ac.uk. Retrieved 10 September 2017.
  6. 1 2 Foundation, The Fetal Medicine. "The Fetal Medicine Foundation". fetalmedicine.org.
  7. "FMF World Congress | Courses & Congress | Welcome to the Fetal Medicine Foundation". fetalmedicine.org.
  8. "Kypros Nicolaides - H-Index, Webometrics". webometrics.info. Retrieved 21 November 2020.
  9. Fonseca, E. B.; Celik, E.; Parra, M.; Singh, M.; Nicolaides, K. H.; Fetal Medicine Foundation Second Trimester Screening Group (2007). "Progesterone and the Risk of Preterm Birth among Women with a Short Cervix". The New England Journal of Medicine. 357 (5): 462–469. doi: 10.1056/NEJMoa067815 . PMID   17671254.
  10. Rolnik, D. L.; Wright, D.; Poon, L. C.; O'Gorman, N.; Syngelaki, A.; De Paco Matallana, C.; Akolekar, R.; Cicero, S.; Janga, D.; Singh, M.; Molina, F. S.; Persico, N.; Jani, J. C.; Plasencia, W.; Papaioannou, G.; Tenenbaum-Gavish, K.; Meiri, H.; Gizurarson, S.; MacLagan, K.; Nicolaides, K. H. (2017). "Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia". The New England Journal of Medicine. 377 (7): 613–622. doi:10.1056/nejmoa1704559. PMID   28657417. S2CID   1605902.
  11. Nicolaides, K. H.; Azar, G.; Byrne, D.; Mansur, C.; Marks, K. (1992). "Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy". BMJ (Clinical Research Ed.). 304 (6831): 867–869. doi:10.1136/bmj.304.6831.867. PMC   1882788 . PMID   1392745.
  12. Snijders, RJM; Noble, P.; Sebire, N.; Souka, A.; Nicolaides, KH (1998). "UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation". The Lancet. 352 (9125): 343–346. doi:10.1016/S0140-6736(97)11280-6. PMID   9717920. S2CID   19797494.
  13. Nicolaides, K.H.; Gabbe, S.G.; Campbell, S.; Guidetti, R. (1986). "Ultrasound Screening for Spina Bifida: Cranial and Cerebellar Signs". The Lancet. 328 (8498): 72–74. doi:10.1016/S0140-6736(86)91610-7. PMID   2425202. S2CID   31571221.
  14. Nicolaides, K. H.; Soothill, P. W.; Rodeck, C. H.; Clewell, W. (12 January 1986). "Rh disease: intravascular fetal blood transfusion by cordocentesis". Fetal Therapy. 1 (4): 185–192. doi:10.1159/000262267. PMID   3136620.
  15. Nicolaides, K.H.; Clewell, W.H.; Mibashan, R.S.; Soothill, P.W.; Rodeck, C.H.; Campbell, S. (1988). "Fetal Haemoglobin Measurement in the Assessment of Red Cell Isoimmunisation". The Lancet. 331 (8594): 1073–1075. doi:10.1016/S0140-6736(88)91896-X. PMID   2452938. S2CID   13275361.
  16. Nicolaides, K. H.; Azar, G. B. (12 January 1990). "Thoraco-amniotic shunting". Fetal Diagnosis and Therapy. 5 (3–4): 153–164. doi:10.1159/000263586. PMID   2130840.
  17. Ville, Y.; Hyett, J.; Hecher, K.; Nicolaides, K. (1995). "Preliminary Experience with Endoscopic Laser Surgery for Severe Twin–Twin Transfusion Syndrome". The New England Journal of Medicine. 332 (4): 224–227. doi: 10.1056/NEJM199501263320404 . PMID   7808488.
  18. Deprest, J.; Gratacos, E.; Nicolaides, K. H.; FETO Task Group (2004). "Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia: Evolution of a technique and preliminary results". Ultrasound in Obstetrics & Gynecology. 24 (2): 121–126. doi:10.1002/uog.1711. PMID   15287047. S2CID   72778891.
  19. Nicolaides, Kypros H. (12 January 2011). "Turning the pyramid of prenatal care". Fetal Diagnosis and Therapy. 29 (3): 183–196. doi:10.1159/000324320. PMID   21389681. S2CID   45772713.
  20. "Surgery in the womb: miracle maker for NHS's tiniest patients". The Guardian. 29 January 2016. ISSN   0261-3077 . Retrieved 10 September 2017.
  21. "Erich Saling Awardee – WAPM – World Association of Perinatal Medicine".
  22. ""IAPM"".
  23. "European Association of Perinatal Medicine - EAPM". europerinatal.eu.
  24. "RCOG announcement: 2014 winner of the Eardley Holland Gold Medal". Royal College of Obstetricians & Gynaecologists.
  25. "Naguib "Mahfouz Award".
  26. "KU "Leuven".
  27. "The "Hong Kong College of Obstetricians and Gynaecologists".
  28. "Ο Κύπρος Νικολαΐδης παρασημοφορήθηκε με τον Χρυσό Σταυρό του Τάγματος του Φοίνικα (εικόνες)". antenna.gr.
  29. BBC News "Life Before Birth" for 'miracle doctor'
  30. 1 2 BBC News "The Surgeon's Cut"